With the swelling and pain of the surgery, doctors are scrambling to make sure their patients get the best care possible.
Now, with the advent of new drugs to treat the disease, doctors may be on the verge of a major breakthrough.
“We’ve got some new drugs that could potentially help with the swelling,” said Dr. Thomas W. Davis, director of the Division of Emergency Medicine at University of North Carolina at Chapel Hill.
He spoke at a recent meeting of the American Society of Nephrology.
“And, I don’t know how quickly they’ll work but we’ve got a chance.”
The drugs that Davis mentioned, known as clopidogrel and cefazolin, are already approved by the Food and Drug Administration and approved by several states.
They are not approved for use in patients with underlying or potentially fatal COVID-19.
So how do they help?
Davis said the drugs work by reducing inflammation and blocking COVID enzymes that can cause inflammation in the body.
In some patients, it can also lower blood pressure, which can be helpful if you have other conditions that are known to affect blood pressure.
The drugs are being tested by patients in a trial in the United Kingdom.
Davis said a small amount of clopridogrel is available, and if the drug is approved, it could be available in the U.S. by the end of next year.
A small dose of cefavirin, which is being tested in some trials, is also being tested.
The clopids are also being used to treat patients who have been given a combination of COVID drugs and radiotherapy, a therapy to treat COVID that is currently used to relieve the pain and swelling caused by surgery.
In addition to the drugs, the U,N.
has launched a COVID treatment trial in patients who are already receiving a combination treatment.
It will take about six months to complete.
Doctors say there are many other treatments that could help the swelling in patients treated with clopristol, which has been approved in some countries, including the United States.
A trial in New Zealand has shown that a dose of a nonsteroidal anti-inflammatory drug (NSAID), also known as ibuprofen, could reduce the swelling.
The drug, also known by its brand name Advil, has been shown to decrease swelling in COVID patients.
Davis also said he was optimistic about the development of a vaccine that will target COVID viruses.
“The vaccine is a major milestone in terms of the ability to prevent the coronavirus from spreading,” he said.
“I don’t think it will take us a year or more to get a vaccine to be able to stop it.”
A vaccine would be a vaccine of the virus that causes the disease and would be given to those who were vaccinated before the pandemic.
In other words, if you get the vaccine now, you would get it as soon as possible.
If you don’t get the vaccination, you won’t be able get the medicine, Davis said.
Davis is not optimistic that the vaccine will work.
The U.N. and other health agencies have said that the virus is already on the path to becoming a pandemic, so there’s little reason to believe that a vaccine would have much of an impact.
However, it may not be too long before other health organizations say that vaccines will be required for people to get vaccinated against COVID.
If that happens, it would be one more step toward stopping the virus from becoming more widespread.
Davis hopes that more scientists will take up the issue.
“Hopefully we’ll have a vaccine within five to 10 years,” Davis said of the vaccine.
“That would be the magic number.”